Medibank Private Limited
MDBPF · OTC
6/30/2025 | 12/30/2024 | 6/30/2024 | 12/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.36 | -0.03 | 0.03 | 0.24 |
| FCF Yield | 4.77% | -2.08% | 9.69% | 1.48% |
| EV / EBITDA | 32.46 | 16.75 | 27.91 | 11.56 |
| Quality | ||||
| ROIC | -49.87% | 67.55% | 28.75% | 61.45% |
| Gross Margin | -59.98% | 100.00% | 99.54% | 100.00% |
| Cash Conversion Ratio | 3.46 | -0.51 | -2.37 | 0.71 |
| Growth | ||||
| Revenue 3-Year CAGR | 1.70% | 1.22% | -0.13% | -0.26% |
| Free Cash Flow Growth | 402.24% | -122.86% | 708.49% | -70.08% |
| Safety | ||||
| Net Debt / EBITDA | -1.92 | -0.91 | -1.70 | -0.91 |
| Interest Coverage | -341.38 | 3,395.25 | 789.76 | 2,360.81 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | -818.10 | 0.00 |